Thus, our data suggest that DR6 functions as an oncogene to promote the malignant progression of CRC cells, which are consistent with the previous studies (Xu et al. 2022; Stegmann et al. 2022; Shi et al. 2018; Yang et al. 2012, 2016). Here, TNFRSF21 is linked to colorectal carcinoma.